Clinical Severity Staging System and Response to Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea

Area of Science:

• Sleep Medicine
• Otolaryngology
• Biomedical Engineering

Background:

• Obstructive sleep apnea (OSA) affects millions, with many intolerant to continuous positive airway pressure (CPAP).
• Hypoglossal nerve stimulation (HGNS) offers an alternative treatment, but patient selection remains a challenge.
• Identifying predictors of HGNS success is crucial for optimizing patient outcomes.

Purpose of the Study:

• To identify baseline factors associated with treatment response to HGNS in OSA patients.
• To develop a prognostic stratification system for predicting HGNS efficacy.
• To improve patient selection for HGNS therapy.

Main Methods:

• Retrospective cohort study of 119 OSA patients who underwent HGNS implantation.
• Analysis of pre- and post-implant sleep study data (apnea-hypopnea index [AHI]).
• Evaluation of baseline factors including neck size, body mass index (BMI), and comorbidity burden.

Main Results:

• 70% of patients (83 of 119) were responders, defined by >50% AHI reduction and post-implant AHI <15.
• Neck size, BMI, AHI score, and comorbidity burden were significantly associated with HGNS response.
• A 4-category staging system demonstrated moderate discriminative power (C-statistic = 0.68).

Conclusions:

• Neck size, BMI, AHI, and comorbidities are key predictors of HGNS response in OSA.
• A clinical staging system using these factors can aid in identifying likely responders.
• Further validation in independent cohorts is necessary to confirm the utility of this staging system.